Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 2
2023 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Early-Onset Colorectal Cancer in a Young Woman with Type 1 Gaucher Disease.
Ridova N, Trajkova S, Popova-Labachevska M, Stojanovska-Jakimovska S, Nikolov F, Panovska-Stavridis I. Ridova N, et al. Among authors: popova labachevska m. Eur J Case Rep Intern Med. 2022 Jun 15;9(6):003412. doi: 10.12890/2022_003412. eCollection 2022. Eur J Case Rep Intern Med. 2022. PMID: 35821905 Free PMC article.
Gaucher disease in North Macedonia: Unexpected prevalence of the N370S GBA1 allele with attenuated disease expression.
Ridova N, Trajkova S, Chonevska B, Stojanoski Z, Ivanovski M, Popova-Labachevska M, Stojanovska-Jakimovska S, Filipche V, Sofijanova A, Panovska-Stavridis I. Ridova N, et al. Among authors: popova labachevska m. Mol Genet Metab Rep. 2022 Jul 8;32:100895. doi: 10.1016/j.ymgmr.2022.100895. eCollection 2022 Sep. Mol Genet Metab Rep. 2022. PMID: 35845720 Free PMC article.
Effectiveness of Ropeginterferon Alfa-2B in High-Risk Patients with Philadelphia Chromosome Negative Myeloproliferative Neoplasms- Evaluation of Clinicohaematologic Response, and Safety Profile: Single Centre Experience.
Popova-Labachevska M, Cvetanoski M, Ridova N, Trajkova S, Stojanovska-Jakimovska S, Mojsovska T, Stojanoski Z, Pivkova-Veljanovska A, Panovska-Stavridis I. Popova-Labachevska M, et al. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2023 Dec 18;44(3):57-62. doi: 10.2478/prilozi-2023-0047. Print 2023 Dec 1. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2023. PMID: 38109450 Free article.
Response Rate in CLL Patients Treated with Obinutuzumab - Single Centre Experience from University Clinic of Hematology, Skopje.
Janev OG, Mojsovska T, Stojanoski M, Pavkovic M, Labachevska MP, Chadievski L, Veljanovska AP, Stojanoski Z, Stavrikj SG. Janev OG, et al. Among authors: labachevska mp. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2026 Mar 21;47(1):93-100. doi: 10.2478/prilozi-2026-0010. Print 2026 Mar 1. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2026. PMID: 41863112 Free article.